ResMed is a global developer of cloud-connected medical devices and digital health technologies focused primarily on sleep apnea, COPD, and other chronic respiratory conditions. Its product portfolio includes CPAP systems, ventilation devices, diagnostic products, mask systems, headgear, accessories, and dental devices, complemented by cloud-based software platforms for remote patient monitoring and clinical management. The company also provides management software for durable and home medical equipment providers, skilled nursing facilities, senior living communities, and home health and hospice providers.
ResMed employs more than 10,600 people and distributes products in more than 140 countries through wholly owned subsidiaries and independent distributors. In May 2025, the company acquired VirtuOx, a software-enabled independent diagnostic testing facility specializing in home-based sleep, respiratory, and cardiac testing across the United States, strengthening its end-to-end solutions capability. The company was founded in 1989 and pioneered the first successful non-invasive treatment for obstructive sleep apnea.
Sleep And Breathing Health 88% · Residential Care Software 12%
business segments · FY2025 (ended Jun 2025) · share of tagged segment revenue (10-K XBRL, as filed)
